Subgraphs in random networks

Understanding the subgraph distribution in random networks is important for modelling complex systems. In classic Erdos networks, which exhibit a Poissonian degree distribution, the number of appearances of a subgraph G with n nodes and g edges scales with network size as \mean{G} ~ N^{n-g}. However, many natural networks have a non-Poissonian degree distribution. Here we present approximate equations for the average number of subgraphs in an ensemble of random sparse directed networks, characterized by an arbitrary degree sequence. We find new scaling rules for the commonly occurring case of directed scale-free networks, in which the outgoing degree distribution scales as P(k) ~ k^{-\gamma}. Considering the power exponent of the degree distribution, \gamma, as a control parameter, we show that random networks exhibit transitions between three regimes. In each regime the subgraph number of appearances follows a different scaling law, \mean{G} ~ N^{\alpha}, where \alpha=n-g+s-1 for \gamma<2, \alpha=n-g+s+1-\gamma for 2<\gamma<\gamma_c, and \alpha=n-g for \gamma>\gamma_c, s is the maximal outdegree in the subgraph, and \gamma_c=s+1. We find that certain subgraphs appear much more frequently than in Erdos networks. These results are in very good agreement with numerical simulations. This has implications for detecting network motifs, subgraphs that occur in natural networks significantly more than in their randomized counterparts.Comment: 8 pages, 5 figure

Una pretensión desmedida, pero necesaria

Presentación del número 11 de la revista Renglones con el tema de Cultura. La cultura como concepto ha sido estudiada desde diferentes enfoques, ramas del saber o tradiciones científicas, todas contribuyendo con su propia versión de lo que es cultura. Se revisan algunas definiciones realizadas por Edward Burnet Tylor, Antonio Gramsci, Gilberto Giménez y Pierre Bourdieu. Se enfatiza en la importancia de la producción y del estudio de la cultura desde la universidad y se da una introducción a los textos presentados en esta edición

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Interaction between oestradiol and the IGF-I signal transduction pathway in breast cancer cells

SIGLEAvailable from British Library Document Supply Centre-DSC:DXN022987 / BLDSC - British Library Document Supply CentreGBUnited Kingdo